Treatment of Chlamydia-associated ocular disease via a recombinant protein based vaccine in the koala (Phascolarctos cinereus)

详细信息    查看全文

• 作者：Courtney Waugh^a ; ^{cwaugh@usc.edu.au" class="auth_mail" title="E-mail the corresponding author} ; Ray Austin^b ; Adam Polkinghorne^a ; ^{apolking@usc.edu.au" class="auth_mail" title="E-mail the corresponding author} ; ^{keenvet@westnet.com.au" class="auth_mail" title="E-mail the corresponding author} ; Peter Timms^a ; ^{ptimms@usc.edu.au" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Vaccine ; Koala ; Chlamydia pecorum ; Therapeutic vaccine ; Major Outer Membrane Protein
• 刊名：Biologicals
• 出版年：2016
• 出版时间：November 2016
• 年：2016
• 卷：44
• 期：6
• 页码：588-590
• 全文大小：351 K

文摘

Koalas (Phascolarctos cinereus) are affected by debilitating chlamydial disease that can lead to blindness, infertility, and death. The causative agent is the intracellular bacterium Chlamydia pecorum. While antibiotics can be used to treat koala chlamydial infection, they are often ineffective or cause severe dysbiosis to the animal's unique gut flora. Recent work has progressed on the development of a protective vaccine for Chlamydia in the koala. This study demonstrates that the use of a vaccine can have a positive effect in koalas already with clinical signs of ocular disease, suggesting a possible therapeutic effect and an alternative to antibiotic therapy.